OnKure Therapeutics (OKUR) Insider Trading & Ownership $2.15 0.00 (0.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.17 +0.02 (+0.93%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock OnKure Therapeutics (NASDAQ:OKUR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$3.41 M Get OKUR Insider Trade Alerts Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OKUR Insider Buying and Selling by Quarter OnKure Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2025Cormorant Asset Management, LpMajor ShareholderSell1,813,439$1.85$3,354,862.15 5/12/2025Cormorant Asset Management, LpMajor ShareholderSell24,300$1.99$48,357.00 4/7/2025Jason A LeveroneCFOSell1,844$2.67$4,923.48 4/7/2025Nicholas A SaccomanoCEOSell516$2.67$1,377.72 4/4/2025Jason A LeveroneCFOSell1,278$3.33$4,255.74 4/4/2025Nicholas A SaccomanoCEOSell358$3.33$1,192.14 (Data available from 1/1/2013 forward) OKUR Insider Trading Activity - Frequently Asked Questions Who is on OnKure Therapeutics's Insider Roster? The list of insiders at OnKure Therapeutics includes Cormorant Asset Management, Lp, Jason A Leverone, and Nicholas A Saccomano. Learn more on insiders at OKUR. What percentage of OnKure Therapeutics stock is owned by insiders? 2.30% of OnKure Therapeutics stock is owned by insiders. Learn more on OKUR's insider holdings. Which OnKure Therapeutics insiders have been selling company stock? The following insiders have sold OKUR shares in the last 24 months: Cormorant Asset Management, Lp ($3,403,219.15), Jason A Leverone ($9,179.22), and Nicholas A Saccomano ($2,569.86). How much insider selling is happening at OnKure Therapeutics? Insiders have sold a total of 1,841,735 OnKure Therapeutics shares in the last 24 months for a total of $3,414,968.23 sold. More Insider Trading Tools from MarketBeat Related Companies ALTS Insider Transactions VIGL Insider Transactions VXRT Insider Transactions NMRA Insider Transactions LXEO Insider Transactions SGMT Insider Transactions MDCX Insider Transactions VTYX Insider Transactions VIRI Insider Transactions MGNX Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:OKUR) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OKUR Stock Free OKUR Stock Alerts